Multi-Year Efficacy Study of Fluzone High-Dose Trivalent Vaccine Compared With Fluzone Vaccine In Adults greater or equal to 65 Years of Age.
Phase of Trial: Phase III
Latest Information Update: 18 Dec 2012
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 12 Aug 2011 Planned end date changed from 1 Feb 2013 to 1 Apr 2012 as reported by ClinicalTrials.gov.
- 24 Sep 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 18 Sep 2009 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History